These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7865231)
1. Detection of structural aberrations of chromosome 17 in malignant gliomas by fluorescence in situ hybridization (FISH). Kwak T; Nishizaki T; Nakayama H; Kakino S; Ito H; Kimura Y Acta Oncol; 1995; 34(1):27-30. PubMed ID: 7865231 [TBL] [Abstract][Full Text] [Related]
2. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas. Willert JR; Daneshvar L; Sheffield VC; Cogen PH Genes Chromosomes Cancer; 1995 Mar; 12(3):165-72. PubMed ID: 7536455 [TBL] [Abstract][Full Text] [Related]
3. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF; Miller DC; Koslow M; Newcomb EW J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [TBL] [Abstract][Full Text] [Related]
4. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255 [TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of genomic abnormalities in human gliomas. Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086 [TBL] [Abstract][Full Text] [Related]
6. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850 [TBL] [Abstract][Full Text] [Related]
7. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas. Arslantas A; Artan S; Oner U; Müslümanoglu MH; Ozdemir M; Durmaz R; Arslantas D; Vural M; Cosan E; Atasoy MA Pathol Oncol Res; 2007; 13(1):39-46. PubMed ID: 17387387 [TBL] [Abstract][Full Text] [Related]
8. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia. Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas. Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230 [TBL] [Abstract][Full Text] [Related]
10. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry). Kasai H; Kawamoto K Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734 [TBL] [Abstract][Full Text] [Related]
11. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay. Takahashi Y; Nagata T; Asai S; Shintaku K; Eguchi T; Ishii Y; Fujii M; Ishikawa K Cancer Genet Cytogenet; 2000 Aug; 121(1):38-43. PubMed ID: 10958939 [TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461 [TBL] [Abstract][Full Text] [Related]
14. Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas. Dalrymple SJ; Herath JF; Ritland SR; Moertel CA; Jenkins RB J Neurosurg; 1995 Aug; 83(2):316-23. PubMed ID: 7616278 [TBL] [Abstract][Full Text] [Related]
15. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Sauter G; Deng G; Moch H; Kerschmann R; Matsumura K; De Vries S; George T; Fuentes J; Carroll P; Mihatsch MJ Am J Pathol; 1994 Apr; 144(4):756-66. PubMed ID: 8160775 [TBL] [Abstract][Full Text] [Related]
16. Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression. Li X; Tsuji T; Wen S; Mimura Y; Sasaki K; Shinozaki F Cancer; 1997 Jun; 79(12):2314-9. PubMed ID: 9191518 [TBL] [Abstract][Full Text] [Related]
18. [Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification]. Lhotská H; Zemanová Z; Kramář F; Lizcová L; Svobodová K; Ransdorfová S; Bystřická D; Krejčík Z; Hrabal P; Dohnalová A; Kaiser M; Michalová K Klin Onkol; 2014; 27(3):183-91. PubMed ID: 24918277 [TBL] [Abstract][Full Text] [Related]
19. High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2. Scheurlen WG; Seranski P; Mincheva A; Kühl J; Sörensen N; Krauss J; Lichter P; Poustka A; Wilgenbus KK Genes Chromosomes Cancer; 1997 Jan; 18(1):50-8. PubMed ID: 8993980 [TBL] [Abstract][Full Text] [Related]
20. Early proliferation enhancement by monosomy 10 and intratumor heterogeneity in malignant human gliomas as revealed by smear preparations from biopsies. Steilen-Gimbel H; Henn W; Kolles H; Moringlane JR; Feiden W; Steudel WI; Zang KD Genes Chromosomes Cancer; 1996 Jul; 16(3):180-4. PubMed ID: 8814450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]